Equities research analysts forecast that bluebird bio Inc (NASDAQ:BLUE) will report sales of $5.77 million for the current fiscal quarter, Zacks Investment Research reports. Six analysts have made estimates for bluebird bio’s earnings, with the lowest sales estimate coming in at $4.14 million and the highest estimate coming in at $8.90 million. bluebird bio reported […]